V

VolitionRX Limited
D

VNRX

0.68880
USD
0.09
(14.67%)
Market Closed
Volume
1,397
EPS
0
Div Yield
0
P/E
-2
Market Cap
63,439,499
OverviewSignalsIdeasNews
Related Instruments
    B
    BNTX
    -5.530
    (-6.42%)
    80.570 USD
    I
    INO
    -0.670
    (-6.28%)
    10.000 USD
    MRNA
    -25.020
    (-20.99%)
    94.160 USD
    M
    MRNS
    0.00000
    (0.00%)
    1.40000 USD
    N
    NVAX
    -0.250
    (-1.95%)
    12.560 USD
    V
    VIR
    -0.43000
    (-4.22%)
    9.75000 USD
    V
    VXRT
    -0.01170
    (-1.74%)
    0.65890 USD
    More
News

Title: VolitionRX Limited

Sector: Healthcare
Industry: Diagnostics & Research
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.